The discovery of higher genomic instability and a better understanding of the importance of tumour-infiltrating lymphocytes (TILs), programmed death ligand 1 (PD-L1) expression and tumor microenvironment (TME), paved the way for clinical trials testing ICIs in TNBC [11]. Here, CD274 is linked to neoplasm.